Use of a2a adenosine receptor agonists

Details Use of a2a adenosine receptor agonists Use of a2a adenosine receptor agonists

A - Human Necessities

61

K

A61K 31/7076 (2006.01) A61K 31/00 (2006.01) A61K 47/00 (2006.01) A61K 49/00 (2006.01) A61K 49/22 (2006.01) A61P 9/00 (2006.01) A61P 9/08 (2006.01) A61P 9/10 (2006.01)

Patent

CA 2583185

Myocardial imaging methods that are accomplished by administering doses of a pharmaceutical composition including regadenoson - an adenosine A2A receptor agonist - to a human undergoing myocardial imaging in an amount sufficient to achieve at least a minimal increase in average coronary peak flow velocity.

L'invention concerne des procédés d'imagerie myocardique effectués par administration de doses d'une composition pharmaceutique comprenant du regadenoson, un agoniste du récepteur de l'adénosine A2A, à un humain passant un examen d'imagerie myocardique, à une quantité suffisante pour obtenir au moins une augmentation minimale de la vitesse moyenne du débit de pointe coronaire.

Affiliated with

Also associated with

Rating

Use of a2a adenosine receptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of a2a adenosine receptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of a2a adenosine receptor agonists will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1438929